Market Closed -
Deutsche Boerse AG
01:28:03 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
208
EUR
|
-1.89%
|
|
+0.48%
|
+0.97%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,037
|
1,002
|
1,264
|
1,197
|
738.8
|
731.7
|
Enterprise Value (EV)
1 |
943.5
|
980.2
|
1,095
|
1,122
|
892.8
|
842.3
|
P/E ratio
|
13.1
x
|
17.2
x
|
11.9
x
|
12.6
x
|
20.4
x
|
25.7
x
|
Yield
|
2.4%
|
2.48%
|
2.25%
|
2.37%
|
3.85%
|
3.88%
|
Capitalization / Revenue
|
0.49
x
|
0.46
x
|
0.52
x
|
0.52
x
|
0.32
x
|
0.31
x
|
EV / Revenue
|
0.44
x
|
0.45
x
|
0.45
x
|
0.49
x
|
0.38
x
|
0.36
x
|
EV / EBITDA
|
4.86
x
|
5.39
x
|
3.84
x
|
5.33
x
|
7.08
x
|
8.62
x
|
EV / FCF
|
15
x
|
14.9
x
|
5.82
x
|
-24.8
x
|
-7.19
x
|
9.14
x
|
FCF Yield
|
6.65%
|
6.72%
|
17.2%
|
-4.03%
|
-13.9%
|
10.9%
|
Price to Book
|
1.17
x
|
1.13
x
|
1.36
x
|
1.15
x
|
0.68
x
|
0.69
x
|
Nbr of stocks (in thousands)
|
3,552
|
3,552
|
3,552
|
3,552
|
3,552
|
3,552
|
Reference price
2 |
292.0
|
282.0
|
356.0
|
337.0
|
208.0
|
206.0
|
Announcement Date
|
3/20/19
|
3/24/20
|
3/23/21
|
3/22/22
|
3/21/23
|
3/12/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,125
|
2,194
|
2,440
|
2,311
|
2,320
|
2,367
|
EBITDA
1 |
194.1
|
181.8
|
285.2
|
210.7
|
126.2
|
97.76
|
EBIT
1 |
128
|
103.9
|
219.7
|
142
|
53.05
|
22.34
|
Operating Margin
|
6.02%
|
4.74%
|
9.01%
|
6.15%
|
2.29%
|
0.94%
|
Earnings before Tax (EBT)
1 |
120.7
|
98.05
|
159.8
|
135.2
|
60.61
|
48.87
|
Net income
1 |
79.02
|
58.27
|
106.5
|
94.67
|
36.15
|
28.42
|
Net margin
|
3.72%
|
2.66%
|
4.36%
|
4.1%
|
1.56%
|
1.2%
|
EPS
2 |
22.25
|
16.41
|
29.98
|
26.66
|
10.18
|
8.002
|
Free Cash Flow
1 |
62.78
|
65.85
|
188.2
|
-45.24
|
-124.2
|
92.13
|
FCF margin
|
2.95%
|
3%
|
7.71%
|
-1.96%
|
-5.35%
|
3.89%
|
FCF Conversion (EBITDA)
|
32.35%
|
36.22%
|
65.97%
|
-
|
-
|
94.25%
|
FCF Conversion (Net income)
|
79.46%
|
113.02%
|
176.73%
|
-
|
-
|
324.16%
|
Dividend per Share
2 |
7.000
|
7.000
|
8.000
|
8.000
|
8.000
|
8.000
|
Announcement Date
|
3/20/19
|
3/24/20
|
3/23/21
|
3/22/22
|
3/21/23
|
3/12/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
154
|
111
|
Net Cash position
1 |
93.6
|
21.4
|
169
|
74.5
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
1.221
x
|
1.132
x
|
Free Cash Flow
1 |
62.8
|
65.9
|
188
|
-45.2
|
-124
|
92.1
|
ROE (net income / shareholders' equity)
|
9.42%
|
6.78%
|
11.9%
|
9.4%
|
3.55%
|
2.92%
|
ROA (Net income/ Total Assets)
|
5.46%
|
4.18%
|
8.22%
|
4.99%
|
1.73%
|
0.7%
|
Assets
1 |
1,448
|
1,394
|
1,295
|
1,896
|
2,089
|
4,065
|
Book Value Per Share
2 |
249.0
|
250.0
|
261.0
|
294.0
|
304.0
|
299.0
|
Cash Flow per Share
2 |
30.20
|
32.40
|
71.60
|
42.50
|
30.40
|
40.90
|
Capex
1 |
84.7
|
85.7
|
112
|
129
|
118
|
113
|
Capex / Sales
|
3.99%
|
3.91%
|
4.57%
|
5.59%
|
5.09%
|
4.78%
|
Announcement Date
|
3/20/19
|
3/24/20
|
3/23/21
|
3/22/22
|
3/21/23
|
3/12/24
|
|
1st Jan change
|
Capi.
|
---|
| +0.97% | 789M | | +11.84% | 27.79B | | -32.98% | 2.98B | | -15.97% | 2.52B | | +11.90% | 2.34B | | -1.11% | 1.91B | | -13.37% | 1.83B | | -7.78% | 1.39B | | -0.38% | 1.27B | | +13.51% | 1.12B |
Medical Supplies
|